Medlive Technology Co., Ltd. (2192.HK)
Connects Chinese doctors with digital tools for patient care and medical education.
7.70+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-49.9%
The outlook
Medlive Technology trades at 7.7 with unanimous Strong Buy ratings from analysts, whose average target sits roughly 63% above the current price. The stock sits near its 52-week low but trades mixed against its moving averages, suggesting near-term momentum is uncertain. The valuation appears modest at 14.5x trailing earnings.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 5 analysts
Price trendMixed vs its moving averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +63% vs current price
Analyst price target
~12-month · 5 analysts12.58average target+63.4% vs now
Now 7.70
Low 11.02High 17.17
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.70B
52-wk high
16.84
52-wk low
6.31
50-day avg
7.35
200-day avg
9.21
Trailing P/E
14.5